We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSRM icon
3376
SSR Mining
SSRM
$6.66B
$72K ﹤0.01%
3,868
-7,335
-65% -$156K
VCYT icon
3377
Veracyte
VCYT
$3.34B
$72K ﹤0.01%
2,204
-6,368
-74% -$202K
NS
3378
DELISTED
NuStar Energy L.P.
NS
$72K ﹤0.01%
+6,742
New +$90.2K
PNFP icon
3379
Pinnacle Financial Partners Inc
PNFP
$16.3B
$71K ﹤0.01%
2,004
-5,483
-73% -$218K
SWKH
3380
DELISTED
SWK Holdings
SWKH
$71K ﹤0.01%
6,419
-4,618
-42% -$48.3K
TAC icon
3381
TransAlta
TAC
$4.04B
$71K ﹤0.01%
11,583
+4,584
+65% +$28.7K
XRX icon
3382
Xerox
XRX
$407M
$71K ﹤0.01%
3,789
-7,382
-66% -$129K
MRO
3383
DELISTED
Marathon Oil Corporation
MRO
$71K ﹤0.01%
17,239
-6,037
-26% -$31.9K
CELL
3384
DELISTED
PhenomeX Inc. Common Stock
CELL
$71K ﹤0.01%
+933
New +$59.2K
ABEO icon
3385
Abeona Therapeutics
ABEO
$337M
$70K ﹤0.01%
2,776
+2,284
+464% +$144K
ADVM
3386
DELISTED
Adverum Biotechnologies
ADVM
$70K ﹤0.01%
684
-142
-17% -$21.3K
JMIA
3387
Jumia Technologies
JMIA
$782M
$70K ﹤0.01%
8,797
+5,821
+196% +$58.6K
NGD
3388
DELISTED
New Gold Inc
NGD
$70K ﹤0.01%
40,917
-212,559
-84% -$342K
REFR icon
3389
Research Frontiers
REFR
$15.7M
$70K ﹤0.01%
25,752
+19,537
+314% +$56.6K
AGFS
3390
DELISTED
AgroFresh Solutions Inc
AGFS
$70K ﹤0.01%
29,005
+24,466
+539% +$61.2K
AUY
3391
DELISTED
Yamana Gold, Inc.
AUY
$70K ﹤0.01%
12,416
-3,271
-21% -$19.6K
ANAB icon
3392
AnaptysBio
ANAB
$1.67B
$69K ﹤0.01%
4,668
+1,934
+71% +$34.9K
FWONA icon
3393
Liberty Media Series A
FWONA
$24.1B
$69K ﹤0.01%
2,150
-1,364
-39% -$44.2K
FYT icon
3394
First Trust Small Cap Value AlphaDEX Fund
FYT
$202M
$69K ﹤0.01%
2,234
-24,158
-92% -$765K
NXST icon
3395
Nexstar Media Group
NXST
$5.83B
$69K ﹤0.01%
766
+700
+1,061% +$63.2K
PGEN icon
3396
Precigen
PGEN
$2.25B
$69K ﹤0.01%
19,698
+6,070
+45% +$28.8K
XGN icon
3397
Exagen
XGN
$159M
$69K ﹤0.01%
6,364
+5,566
+697% +$71.7K
CZZ
3398
DELISTED
Cosan Limited
CZZ
$69K ﹤0.01%
4,654
+4,234
+1,008% +$74.7K
ELMD icon
3399
Electromed
ELMD
$347M
$68K ﹤0.01%
6,573
+5,855
+815% +$84.2K
HRTX icon
3400
Heron Therapeutics
HRTX
$63.3M
$68K ﹤0.01%
4,598
-5,269
-53% -$82.2K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.